T-Knife’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

T-Knife is a biotechnology company that develops and commercializes T-cell receptor-based therapeutics for the treatment of cancer. Read more

Elisa Kieback's photo - Co-Founder & CEO of T-Knife

Co-Founder & CEO

Elisa Kieback

CEO Approval Rating

90/100

Founded:

2018

Status:

Est. Annual Revenue
Est. Employees

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Juno has been one of T-Knife's top competitors. Juno is a Private company that was founded in 2013 in Seattle, Washington. Like T-Knife, Juno also competes in the Biotechnology sector. Compared to T-Knife, Juno has 633 more employees.

Medigene is seen as one of T-Knife's biggest rivals. Medigene is a Public company that was founded in Martinsried, Bavaria in 1994. Like T-Knife, Medigene also operates in the Biotechnology sector. Medigene has 112 more employees vs. T-Knife.

Immatics is perceived as one of T-Knife's biggest rivals. Immatics was founded in Tuebingen, Baden-Württemberg} in 2000. Like T-Knife, Immatics also competes in the Biotechnology space. Compared to T-Knife, Immatics generates $44.5M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of T-Knife?

Acquisitions

No recent acquisitions found related to T-Knife

T-Knife Funding History

$78.4M

Since T-Knife was founded in 2018, it has participated in 1 round of funding. In total T-Knife has raised $78.4M. T-Knife's funding round was on Aug 2020 for a total of $78.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Aug 2020
$78.4M

Versant Ventures

Total Funding: $78.4M

Since T-Knife was founded in 2018, it has participated in 1 round of funding. In total T-Knife has raised $78.4M. T-Knife's funding round was on Aug 2020 for a total of $78.4M

Investments

No recent investments found related to T-Knife

T-Knife News

August 6, 2020FierceBiotech

Versant, RA Capital tee T-knife up apply TCRs to solid tumors

Versant, RA Capital tee T-knife up apply TCRs to solid tumors ntaylor Thu, 08/06/2020 - 05:00... See more »

Headquarters

Robert-Roessle-Str. 10

Berlin, Berlin13125

49-30-94892432

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

T-Knife is a biotechnology company that develops and commercializes T-cell receptor-based therapeutics for the treatment of cancer. T-Knife was founded in 2018. T-Knife's headquarters is located in Berlin, Berlin, DE 13125. It has raised 78.4M in 1 ro...

CEO

T-Knife's Co-Founder & CEO, Elisa Kieback, currently has an approval rating of 90%. T-Knife's primary competitors are Juno, Medigene & Immatics.

Website

t-knife.com

Frequently Asked Questions about T-Knife

  1. When was T-Knife founded?

    T-Knife was founded in 2018
  2. Who is T-Knife's CEO?

    T-Knife's CEO is Elisa Kieback
  3. How much revenue does T-Knife generate?

    T-Knife generates $2.5M in revenue
  4. How much funding does T-Knife have?

    T-Knife has historically raised $78.4M in funding
  1. Where is T-Knife's headquarters?

    T-Knife's headquarters is in Berlin Berlin, DE
  2. How many employees does T-Knife have?

    T-Knife has 30 employees
  3. What sector does T-Knife operate in?

    T-Knife is in Biotechnology
  4. Who are T-Knife's competitors?

    T-Knife's top competitors are Juno, Medigene, Immatics